The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension
Open accessAbstract
Eplerenone is a highly selective aldosterone blocker, which is under development for the treatment of hypertension and heart failure. To assess its usefulness in older patients with systolic hypertension and widened pulse pressure, we compared the effects of eplerenone with amlodipine, on clinic blood pressure (BP) and pulse pressure and in a subset of the patients, ambulatory BP, vascular compliance, and urinary albumin excretion. The study involved 269 patients ≥50 years of age who were randomly assigned to either eplerenone (50 to 200 mg daily) or amlodipine (2.5 to 10 mg daily) in a double-blind titration to effect design. After 24 weeks of therapy, reductions in clinic systolic BP were similar for both treatments (eplerenone, −20.5±1.1 mm Hg; amlodipine, −20.1±1.1 mm Hg). Reductions in clinic diastolic BP were modestly larger on amlodipine (−6.9±0.7 mm Hg) compared with eplerenone (−4.5±0.7 mm Hg) ( P =0.014). Pulse pressure was also reduced similarly from baseline by the 2 treatment groups (eplerenone, −15.9 mm Hg versus amlodipine, −13.4 mm Hg, P =0.07). Changes from baseline in pulse wave velocity after 24 weeks of therapy were statistically similar for eplerenone and amlodipine. In patients with microalbuminuria at baseline (>30 mg albumin/g creatinine), eplerenone reduced the urinary albumin/creatinine ratio by 52% compared with a reduction of 10% by amlodipine ( P =0.04). Thus, eplerenone was as effective as amlodipine in lowering systolic BP and pulse pressure as well as pulse wave velocity in older patients with widened pulse pressure hypertension. Furthermore, eplerenone reduced microalbuminuria to a greater extent than amlodipine in this older patient group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Asmar, R., Benetos, A., Topouchian, J., Laurent, P., Pannier, B., Brisac, A.-M., Target, R., & Levy, B. I. (1995) · Hypertension · doi:10.1161/01.hyp.26.3.485 · Cited by 1,376
Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data
Stamler, J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410050036006 · Cited by 1,015
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Microalbuminuria as predictor of increased mortality in elderly people.
Damsgaard, E. M., Frøland, A., Jørgensen, O. D., & Mogensen, C. E. (1990) · BMJ · doi:10.1136/bmj.300.6720.297 · Cited by 609
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
Weinberger, M. H., Roniker, B., Krause, S. L., & Weiss, R. J. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02957-6 · Cited by 388
Self-citationEfficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
Flack, J. M., Oparil, S., Pratt, J. H., Roniker, B., Garthwaite, S., Kleiman, J. H., Yang, Y., Krause, S. L., Workman, D., & Saunders, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00054-8 · Cited by 224
Self-citationDuprez, D. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1099 · Cited by 191
Self-citationEplerenone: A Selective Aldosterone Receptor Antagonist (SARA)
Delyani, J. A., Rocha, R., Cook, C. S., Tolbert, D. S., Levin, S., Roniker, B., Workman, D. L., Sing, Y. L., & Whelihan, B. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00064.x · Cited by 126
Self-citationThe Diastolic Blood Pressure in Systolic Hypertension
Smulyan, H., & Safar, M. E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-3-200002010-00010 · Cited by 108
Dell’Omo, G., Penno, G., Giorgi, D., Bello, V. D., Mariani, M., & Pedrinelli, R. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33906 · Cited by 92
Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics
White, W. B. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-004-9 · Cited by 87
Self-citationAldosterone Receptor Antagonism Normalizes Vascular Function in Liquorice-Induced Hypertension
Quaschning, T., Ruschitzka, F. T., Shaw, S., & Lüscher, T. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.801 · Cited by 83
Chan, J. C. N., Critchley, J., Tomlinson, B., Chan, T. Y. K., & Cockram, C. S. (1997) · American Journal of Nephrology · doi:10.1159/000169075 · Cited by 66
Derhaschnig, U., Kittler, H., Woisetschläger, C., Bur, A., Herkner, H., & Hirschl, M. M. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.1.81 · Cited by 49
The first report of the Systolic and Pulse Pressure (SYPP) Working Group.
Black, H. R., Kuller, L. H., O’Rourke, M. F., et al. (1999) · PubMed · Cited by 43
Jeunemaı̂tre, X., Charru, A., Châtellier, G., Patrice Degoulet, A., Julien, J., Plouin, P., Corvol, P. L., & Ménard, J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90551-6 · Cited by 39
Benefits of Antihypertensive Therapy in Older Patients With Hypertension
White, W. B. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.149 · Cited by 20
Self-citationLee, R. T., & Huang, H. (2000) · Annals of Medicine · doi:10.3109/07853890009011765 · Cited by 19
White, W. B. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-004-9_13 · Cited by 18
Self-citationThe systolic blood pressure versus pulse pressure controversy
White, W. B. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01519-3 · Cited by 16
Self-citation
Cited by
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl254 · Cited by 6,077
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Authors/Task Force Members:, Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,384
Xiao, L., & Harrison, D. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.01.013 · Cited by 545
Metadata
- Authors
- White, W. B., Duprez, D., St Hillaire, R., Krause, S., Roniker, B., Kuse-Hamilton, J., & Weber, M. A.
- Venue
- Hypertension
- Published
- 2003-05
- Volume
- 41
- Issue
- 5
- Pages
- 1021-1026
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2123778248
- Cited by
- 295
- References
- 26
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.